Alerta Anvisa: Ozempic, mounjaro e Pancreatite - A Verdade Científica

Anvisa (Brazilian Health Regulatory Agency) has issued a warning about pancreatitis associated with GLP-1 analogs (Ozempic, Wegovy, Mounjaro, Saxenda). In this video, I explain clearly and without sensationalism what this really means for you who use or are thinking about using these medications. I will show you where this warning came from, what the VIGIMED system data is, and why we cannot simply say that the medication causes pancreatitis. I also discuss the two main scientific theories about this possible relationship and, above all, what changes in practice. The big warning here is about the trivialized use for aesthetic purposes. When we talk about diabetes and obesity, the benefits far outweigh the risks. But using it to lose "that little bit of fat"? Then any risk becomes disproportionate. Never practice self-medication. If in doubt, consult a doctor you trust. 📃Schedule a consultation with me 📃 https://api.whatsapp.com/send/?phone=... ------------- Presentation: Gustavo Lenci Marques (CRMPR 29443) Specialist in Cardiology (RQE 2923) and Internal Medicine (RQE 17909) Doctor of Internal Medicine Professor at the Federal University of Paraná and the Pontifical Catholic University of Paraná Social Media: Instagram:   / gustavolencimarques   Twitter:   / lencimarques   Edited by: @LukasOEditor